Keywords: UK, NICE< Roche, Tarceva, NSCLC, Allergan, Botox, Migraine

UK NICE asks for more data on Tarceva, and Botox for migraine

Article | 17 February 2012

Print This

UK drug watchdog the National Institute for Health and Clinical Excellence (NICE) today issued new draft guidance requesting that Swiss ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in